Current Drug Therapy publishes high-quality original research articles, full-length/mini reviews, and guest-edited thematic issues covering a wide range of topics in drug science, therapy, and medical advancements. The journal encompasses research on:

• Drug discovery, development, and delivery
• Clinical trials and real-world evidence studies
• Pharmacology, toxicology, and drug safety
• Targeted and biologic therapies, including immunotherapy
• Traditional, alternative, and regenerative medicine
• Personalized medicine, pharmacogenomics, and precision therapies
• Artificial intelligence and big data in drug research
• Regulatory science, drug approval processes, and public health perspectives
• Vaccine development, immunization strategies, and epidemiology
• Drug repurposing, repositioning, and novel therapeutic approaches
• Nanotechnology in Drug Delivery
• Gene and Cell Therapies
• Antimicrobial Resistance and Novel Antibiotics
• Neuropharmacology and Psychiatric Drug Development
• Pediatric and Geriatric Pharmacology

The journal serves as an essential resource for researchers, clinicians, and industry professionals working in drug science, healthcare, and therapeutic innovations.

Current Drug Therapy is an international, peer-reviewed journal on all the latest advances in drug therapy and drug clinical trial studies, published monthly (print & online) by Bentham Science Publishers.